93 related articles for article (PubMed ID: 22455969)
21. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
[TBL] [Abstract][Full Text] [Related]
22. Targeting anaplastic lymphoma kinase in lung cancer.
Shaw AT; Solomon B
Clin Cancer Res; 2011 Apr; 17(8):2081-6. PubMed ID: 21288922
[TBL] [Abstract][Full Text] [Related]
23. Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing.
Jung Y; Kim P; Jung Y; Keum J; Kim SN; Choi YS; Do IG; Lee J; Choi SJ; Kim S; Lee JE; Kim J; Lee S; Kim J
Genes Chromosomes Cancer; 2012 Jun; 51(6):590-7. PubMed ID: 22334442
[TBL] [Abstract][Full Text] [Related]
24. Bronchoscopic microsampling is a useful complementary diagnostic tool for detecting lung cancer.
Yasuda H; Soejima K; Nakayama S; Kawada I; Nakachi I; Yoda S; Satomi R; Ikemura S; Terai H; Sato T; Watanabe H; Naoki K; Hayashi Y; Ishizaka A
Lung Cancer; 2011 Apr; 72(1):32-8. PubMed ID: 20813423
[TBL] [Abstract][Full Text] [Related]
25. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer.
Mano H
Cancer Sci; 2008 Dec; 99(12):2349-55. PubMed ID: 19032370
[TBL] [Abstract][Full Text] [Related]
26. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
27. Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion.
Rimkunas VM; Crosby KE; Li D; Hu Y; Kelly ME; Gu TL; Mack JS; Silver MR; Zhou X; Haack H
Clin Cancer Res; 2012 Aug; 18(16):4449-57. PubMed ID: 22661537
[TBL] [Abstract][Full Text] [Related]
28. Incidentally proven pulmonary "ALKoma".
Osoegawa A; Nosaki K; Miyamoto H; Kometani T; Hirai F; Ondo K; Seto T; Sugio K; Choi YL; Soda M; Mano H; Ichinose Y
Intern Med; 2010; 49(6):603-6. PubMed ID: 20228600
[TBL] [Abstract][Full Text] [Related]
29. Variants on a theme: a biomarker of crizotinib response in ALK-positive non-small cell lung cancer?
Crystal AS; Shaw AT
Clin Cancer Res; 2012 Sep; 18(17):4479-81. PubMed ID: 22912388
[TBL] [Abstract][Full Text] [Related]
30. Genomic classification of lung cancer: toward a personalized treatment.
Mlika M; Laabidi S; Afrit M; Boussen H; El Mezni F
Tunis Med; 2015 Jun; 93(6):339-44. PubMed ID: 26644092
[TBL] [Abstract][Full Text] [Related]
31. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
[TBL] [Abstract][Full Text] [Related]
32. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
Sanders HR; Li HR; Bruey JM; Scheerle JA; Meloni-Ehrig AM; Kelly JC; Novick C; Albitar M
Cancer Genet; 2011 Jan; 204(1):45-52. PubMed ID: 21356191
[TBL] [Abstract][Full Text] [Related]
33. Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.
Majewski IJ; Mittempergher L; Davidson NM; Bosma A; Willems SM; Horlings HM; de Rink I; Greger L; Hooijer GK; Peters D; Nederlof PM; Hofland I; de Jong J; Wesseling J; Kluin RJ; Brugman W; Kerkhoven R; Nieboer F; Roepman P; Broeks A; Muley TR; Jassem J; Niklinski J; van Zandwijk N; Brazma A; Oshlack A; van den Heuvel M; Bernards R
J Pathol; 2013 Jul; 230(3):270-6. PubMed ID: 23661334
[TBL] [Abstract][Full Text] [Related]
34. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC; McDermott R
Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
[TBL] [Abstract][Full Text] [Related]
35. ALKoma: a cancer subtype with a shared target.
Mano H
Cancer Discov; 2012 Jun; 2(6):495-502. PubMed ID: 22614325
[TBL] [Abstract][Full Text] [Related]
36. Chipping away at the lung cancer genome.
Pao W; Hutchinson KE
Nat Med; 2012 Mar; 18(3):349-51. PubMed ID: 22395697
[No Abstract] [Full Text] [Related]
37. A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
Pinsolle J; Mondet J; Duruisseaux M; d'Alnoncourt S; Magnat N; de Fraipont F; Moro-Sibilot D; Toffart AC; Brambilla E; McLeer-Florin A
Clin Lung Cancer; 2019 Sep; 20(5):e535-e540. PubMed ID: 31171381
[No Abstract] [Full Text] [Related]
38. [EML4-ALK fusion in non-small-cell lung cancer].
Wang X; Bai CX
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Mar; 34(3):207-9. PubMed ID: 21569690
[No Abstract] [Full Text] [Related]
39. Echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangement in congenital pulmonary airway malformation.
Tetsumoto S; Kijima T; Morii E; Goya S; Minami T; Hirata H; Takahashi R; Kohmo S; Inoue K; Nagatomo I; Takeda Y; Kida H; Tachibana I; Kumanogoh A
Clin Lung Cancer; 2013 Jul; 14(4):457-60. PubMed ID: 23357247
[No Abstract] [Full Text] [Related]
40. More on crizotinib.
Shen L; Ji HF
N Engl J Med; 2011 Feb; 364(8):777-8. PubMed ID: 21345111
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
